These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 23560600

  • 1. A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.
    Treuer T, Gau SS, Méndez L, Montgomery W, Monk JA, Altin M, Wu S, Lin CC, Dueñas HJ.
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):179-93. PubMed ID: 23560600
    [Abstract] [Full Text] [Related]

  • 2. Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.
    Garnock-Jones KP, Keating GM.
    Paediatr Drugs; 2009 Apr; 11(3):203-26. PubMed ID: 19445548
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children.
    Eiland LS, Bell EA, Erramouspe J.
    Ann Pharmacother; 2014 Oct; 48(10):1350-5. PubMed ID: 24982313
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
    Osland ST, Steeves TD, Pringsheim T.
    Cochrane Database Syst Rev; 2018 Jun 26; 6(6):CD007990. PubMed ID: 29944175
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.
    Roskell NS, Setyawan J, Zimovetz EA, Hodgkins P.
    Curr Med Res Opin; 2014 Aug 26; 30(8):1673-85. PubMed ID: 24627974
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
    Santosh PJ, Sattar S, Canagaratnam M.
    CNS Drugs; 2011 Sep 01; 25(9):737-63. PubMed ID: 21870887
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression.
    Cunill R, Castells X, Tobias A, Capellà D.
    Pharmacoepidemiol Drug Saf; 2013 Sep 01; 22(9):961-9. PubMed ID: 23813665
    [Abstract] [Full Text] [Related]

  • 14. Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder : clinical approaches and review of current available evidence.
    Prasad S, Steer C.
    Paediatr Drugs; 2008 Sep 01; 10(1):39-47. PubMed ID: 18162007
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis.
    Cheng JY, Chen RY, Ko JS, Ng EM.
    Psychopharmacology (Berl); 2007 Oct 01; 194(2):197-209. PubMed ID: 17572882
    [Abstract] [Full Text] [Related]

  • 16. An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness.
    Wilens TE, Hammerness P, Utzinger L, Schillinger M, Georgiopoulous A, Doyle RL, Martelon M, Brodziak K.
    J Child Adolesc Psychopharmacol; 2009 Oct 01; 19(5):485-92. PubMed ID: 19877972
    [Abstract] [Full Text] [Related]

  • 17. Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009-2011: focus on clinical efficacy and safety.
    Bushe CJ, Savill NC.
    J Psychopharmacol; 2014 Mar 01; 28(3):204-11. PubMed ID: 23438503
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.
    Fredriksen M, Halmøy A, Faraone SV, Haavik J.
    Eur Neuropsychopharmacol; 2013 Jun 01; 23(6):508-27. PubMed ID: 22917983
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.